Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michael D McLellan
Affiliation
McDonnell Genome Institute, Washington University in St. Louis
ORCID
Career Start Year
2003
Papers
68
H Index
50
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35241842
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Nat Med
2022
35484266
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Nat Med
2022
35241842
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Nat Med
2022
35484266
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Nat Med
2022
34255749
HPV transcript expression affects cervical cancer response to chemoradiation.
JCI Insight
2021
33879241
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.
Genome Med
2021
34255749
HPV transcript expression affects cervical cancer response to chemoradiation.
JCI Insight
2021
33879241
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.
Genome Med
2021
32868873
HPV-EM: an accurate HPV detection and genotyping EM algorithm.
Sci Rep
2020
32868873
HPV-EM: an accurate HPV detection and genotyping EM algorithm.
Sci Rep
2020
29507395
Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types.
Cell Res
2018
29625052
Pathogenic Germline Variants in 10,389 Adult Cancers.
Cell
2018
29438696
The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Cancer Cell
2018
29596782
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
Cell Syst
2018
29507395
Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types.
Cell Res
2018
29438696
The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Cancer Cell
2018
29625052
Pathogenic Germline Variants in 10,389 Adult Cancers.
Cell
2018
29596782
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
Cell Syst
2018
28582538
BreakPoint Surveyor: a pipeline for structural variant visualization.
Bioinformatics
2017
28348404
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.
Nat Commun
2017
28582538
BreakPoint Surveyor: a pipeline for structural variant visualization.
Bioinformatics
2017
28619968
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor Immunity.
Cancer Immunol Res
2017
28747753
Corrigendum: Protein-structure-guided discovery of functional mutations across 19 cancer types.
Nat Genet
2017
28440318
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.
Nat Commun
2017
29423104
Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer.
Oncotarget
2017
28440318
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.
Nat Commun
2017
28348404
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.
Nat Commun
2017
29423104
Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer.
Oncotarget
2017
28619968
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor Immunity.
Cancer Immunol Res
2017
28747753
Corrigendum: Protein-structure-guided discovery of functional mutations across 19 cancer types.
Nat Genet
2017
27251275
Proteogenomics connects somatic mutations to signalling in breast cancer.
Nature
2016
27251275
Proteogenomics connects somatic mutations to signalling in breast cancer.
Nature
2016
27294619
Protein-structure-guided discovery of functional mutations across 19 cancer types.
Nat Genet
2016
26657142
Systematic discovery of complex insertions and deletions in human cancers.
Nat Med
2016
26631509
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.
Mol Cell Proteomics
2016
26631509
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.
Mol Cell Proteomics
2016
26657142
Systematic discovery of complex insertions and deletions in human cancers.
Nat Med
2016
27294619
Protein-structure-guided discovery of functional mutations across 19 cancer types.
Nat Genet
2016
25252869
Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.
Leukemia
2015
25501392
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Nat Genet
2015
26158448
Genome Modeling System: A Knowledge Management Platform for Genomics.
PLoS Comput Biol
2015
26451490
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Cell
2015
26689913
Patterns and functional implications of rare germline variants across 12 cancer types.
Nat Commun
2015
25252869
Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.
Leukemia
2015
26451490
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Cell
2015
26689913
Patterns and functional implications of rare germline variants across 12 cancer types.
Nat Commun
2015
26158448
Genome Modeling System: A Knowledge Management Platform for Genomics.
PLoS Comput Biol
2015
25501392
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Nat Genet
2015
24497850
Re-sequencing expands our understanding of the phenotypic impact of variants at GWAS loci.
PLoS Genet
2014
25326804
Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Nat Med
2014
1 - 50 of 136
Column Actions
Search
Recommended Authors
Ander Diaz-Navarro
Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo
Career Start Year
2018
Number of shared co-authors
6
Aparna Pallavajjala
Johns Hopkins University School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Richard de Borja
The Hospital for Sick Children
Career Start Year
2012
Number of shared co-authors
9
Emilie Lalonde
University of Pennsylvania
Career Start Year
2010
Number of shared co-authors
3
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year
2010
Number of shared co-authors
8
Hyunchul Jung
Wellcome Sanger Institute
Career Start Year
2009
Number of shared co-authors
1
Sabah Kadri
Abbvie Inc., Genomics Research Center
Career Start Year
2009
Number of shared co-authors
1
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Career Start Year
2006
Number of shared co-authors
11
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year
2006
Number of shared co-authors
9
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
16
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year
2006
Number of shared co-authors
53
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year
2005
Number of shared co-authors
13
David Jones
Wellcome Sanger Institute
Career Start Year
2005
Number of shared co-authors
12
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
7
Matthias Schlesner
University of Augsburg
Career Start Year
2004
Number of shared co-authors
12
Keiran Raine
Wellcome Sanger Institute
Career Start Year
2004
Number of shared co-authors
14
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
3
Michael Rusch
St Jude Children's Research Hospital
Career Start Year
2003
Number of shared co-authors
22
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
30
Peter Van Loo
The Francis Crick Institute
Career Start Year
2003
Number of shared co-authors
10
Peter J Campbell
Wellcome Sanger Institute
Career Start Year
2003
Number of shared co-authors
40
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
56
Jon Teague
Wellcome Sanger Institute
Career Start Year
2002
Number of shared co-authors
15
Andrew Menzies
Wellcome Sanger Institute
Career Start Year
2002
Number of shared co-authors
12
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
10
Michael N Edmonson
St. Jude Children's Research Hospital
Career Start Year
1999
Number of shared co-authors
20
Adam Butler
Wellcome Sanger Institute
Career Start Year
1996
Number of shared co-authors
23
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
6
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year
1992
Number of shared co-authors
46
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
22
row(s) 1 - 30 of 30
Collaborators
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
46
Richard K Wilson
The Ohio State University
Co-authored papers
39
Elaine R Mardis
The Ohio State University
Co-authored papers
37
Timothy J Ley
Washington University School of Medicine
Co-authored papers
28
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
25
Michael C Wendl
Washington University in St Louis
Co-authored papers
20
Daniel C Koboldt
Institute for Genomic Medicine, Nationwide Children's Hospital
Co-authored papers
20
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers
19
Christopher A Miller
Washington University School of Medicine
Co-authored papers
19
Timothy A Graubert
Massachusetts General Hospital
Co-authored papers
19
David E Larson
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
19
John F DiPersio
Washington University School of Medicine
Co-authored papers
18
Matthew J Walter
Washington University School of Medicine in St. Louis
Co-authored papers
18
Lucinda Fulton
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
17
Daniel C Link
Washington University School of Medicine
Co-authored papers
16
Cyriac Kandoth
University of California los angeles
Co-authored papers
15
Mark A Watson
Washington University School of Medicine
Co-authored papers
14
Sharon E Heath
Washington University School of Medicine.
Co-authored papers
14
Joshua F McMichael
Washington University
Co-authored papers
14
Qunyuan Zhang
Co-authored papers
14
Beifang Niu
Co-authored papers
13
Peter Westervelt
Washington University School of Medicine
Co-authored papers
13
Jacqueline E Payton
Washington University School of Medicine.
Co-authored papers
11
Vincent Magrini
The Ohio State University
Co-authored papers
11
Charles Lu
Co-authored papers
11
Rakesh Nagarajan
Current or past members of the College of American Pathologists
Co-authored papers
9
Matthew A Wyczalkowski
Washington University in St Louis
Co-authored papers
9
Rhonda E Ries
Clinical Research Division, Fred Hutchinson Cancer Research Center
Co-authored papers
9
Kai Ye
Co-authored papers
9
Matthew J Ellis
Co-authored papers
8
1 - 30